Delivery Order SPE2DB22D3004-SPE2DB24FRA68
Award Date
7/12/24
Potential Completion Date
7/15/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with a ceiling value of $2,113.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,190 units of dexamethasone 4 mg tablets, a medication used to treat various conditions. The contract is a Firm Fixed Price Delivery Order, with a performance period extending through May 9, 2025. The contract is not set aside for any...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVQ36, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,126.85, is a delivery order for the supply of 4,568,203,053 units of dexamethasone 4 mg tablets. The contract is a firm-fixed-price, non-set-aside award with a completion date of May 12, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,723.10, is a Firm-Fixed-Price Delivery Order for the purchase of 4 mg dexamethasone tablets. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of dexamethasone 10 mg/mL vials. The contract, worth $1,862.79, is a firm fixed-price delivery order with a completion date of May 30, 2024. Amerisourcebergen, through its Corporate Office division, is fulfilling this order as part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $5,084.84 Firm Fixed Price Delivery Order is for the supply of 4,567,903,519 units of Dexamethasone 4 mg tablets. The contract has an ultimate completion date of April 15, 2025 and was awarded on April 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The $1,951.28 firm-fixed-price contract is for the delivery of 4,564,404,838 dexamethasone 4 mg tablets over a period ending on April 26, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dexamethasone 10 mg/mL vials. The fixed-price delivery order, valued at $2,176.66, has a period of performance through January 24, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,524.24, is a Firm Fixed Price Delivery Order for the supply of Dexamethasone 10 mg/ml vials. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, with ID SPE2DB22D1202|SPE2DB24FUNY5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Dexamethasone 20 mg/5 ml vials, a critical medical product, with an ultimate completion date of January 30, 2024 and a ceiling value of $2,317.07. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to...
This federal contract award, valued at $9,859.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Dexamethasone 10 mg/mL vials, a medication used to treat various medical conditions. This is a Firm Fixed Price delivery order contract, with an ultimate completion date of April 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and this...